Abstract
The radical-ionic coupling of chloropyrazine-2-carboxylic acid derivatives with methoxybenzenethiols, carried out in the presence of a heterogeneous copper catalyst, provided the series of 6- or 5- or 3-(4-methoxyphenyl)sulfanylpyrazine- 2-carboxylic acid derivatives as well as 6- or 5- or 3-(3-methoxyphenyl)sulfanylpyrazine-2-carboxylic acid derivatives. The prepared compounds were evaluated as potential antifungal agents and new antituberculotics. Their preliminary in vitro evaluation of antimycobacterial activity according to the international program with the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) is presented. Several compounds showed an interesting activity in the preliminary screening with a percentage growth inhibition of the virulent Mycobacterium tuberculosis H37Rv between 50 to 100% at the concentration 6.25 μg/mL. Structure-activity relationships among the chemical structure, the physical properties and the biological activities of the evaluated compounds are discussed in the article.
Keywords: Methoxyphenylsulfanylpyrazine-2-carboxylic acid derivatives, in vitro antimycobacterial activity, in vitro antifungal activity, lipophilicity, structure-activity relationships
Medicinal Chemistry
Title: Antimicrobial Evaluation of Some Arylsulfanylpyrazinecarboxylic Acid Derivatives
Volume: 3 Issue: 3
Author(s): Josef Jampilek, Martin Dolezal and Vladimir Buchta
Affiliation:
Keywords: Methoxyphenylsulfanylpyrazine-2-carboxylic acid derivatives, in vitro antimycobacterial activity, in vitro antifungal activity, lipophilicity, structure-activity relationships
Abstract: The radical-ionic coupling of chloropyrazine-2-carboxylic acid derivatives with methoxybenzenethiols, carried out in the presence of a heterogeneous copper catalyst, provided the series of 6- or 5- or 3-(4-methoxyphenyl)sulfanylpyrazine- 2-carboxylic acid derivatives as well as 6- or 5- or 3-(3-methoxyphenyl)sulfanylpyrazine-2-carboxylic acid derivatives. The prepared compounds were evaluated as potential antifungal agents and new antituberculotics. Their preliminary in vitro evaluation of antimycobacterial activity according to the international program with the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) is presented. Several compounds showed an interesting activity in the preliminary screening with a percentage growth inhibition of the virulent Mycobacterium tuberculosis H37Rv between 50 to 100% at the concentration 6.25 μg/mL. Structure-activity relationships among the chemical structure, the physical properties and the biological activities of the evaluated compounds are discussed in the article.
Export Options
About this article
Cite this article as:
Jampilek Josef, Dolezal Martin and Buchta Vladimir, Antimicrobial Evaluation of Some Arylsulfanylpyrazinecarboxylic Acid Derivatives, Medicinal Chemistry 2007; 3 (3) . https://dx.doi.org/10.2174/157340607780620635
DOI https://dx.doi.org/10.2174/157340607780620635 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Slow-Onset Inhibition of 2-trans-Enoyl-ACP (CoA) Reductase from Mycobacterium tuberculosis by an Inorganic Complex
Current Pharmaceutical Design Nanotechnology-Based Approaches for Combating Tuberculosis: A Review
Current Nanomaterials Genetic Mapping of Pharmacogenetic Regulatory Variation
Current Pharmaceutical Design A Key Role for Altered Dendritic Cell Functioning in the Impaired Immunity Seen in Aged Individuals
Current Immunology Reviews (Discontinued) Meet Our Associate Editor
Current Drug Metabolism Gelrite® Microgels for Sustained Oral Drug Delivery-Formulation and Evaluation
Current Drug Delivery Nanoemulsion-Based Transdermal Drug Delivery System for the Treatment of Tuberculosis
Recent Patents on Anti-Infective Drug Discovery Leishmaniasis: History, Evolution of Treatment and the Need for New Drugs
Current Biotechnology IBD Modern Concepts, Nano Drug Delivery and Patents: An Update
Recent Patents on Nanomedicine Design of multifunctional nanocarriers for delivery of anti-cancer therapy
Current Pharmaceutical Design Current Status on Natural Products with Antitumor Activity from Brazilian Marine Sponges
Current Pharmaceutical Biotechnology Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms
Current Topics in Medicinal Chemistry A Perspective on Clinical Islet Transplantation: Past, Present and Developments for Future
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) <i>Hoslundia opposita</i> Vahl. - A Promising Source of Bioactive Compounds against Infectious and Non-infectious Diseases
Current Traditional Medicine Editorial [ Infectious Disorders Drug Targets - An Arsenal of Knowledge on Pathogen Targets ]
Infectious Disorders - Drug Targets Obtention and Engineering of Non-Human Primate (NHP) Antibodies for Therapeutics
Mini-Reviews in Medicinal Chemistry Regulation and Function of Antimicrobial Peptides in Immunity and Diseases of the Lung
Protein & Peptide Letters Pharmacogenetics Research Developments in Africa: A Focus on Malawi
Current Pharmacogenomics and Personalized Medicine SV40 and HIV Sequences in the Cerebrospinal Fluid of a Patient with AIDS Dementia Complex
Current HIV Research From Nucleic Acids to Drug Discovery: Nucleobases as Emerging Templates for Drug Candidates
Current Medicinal Chemistry